Factors associated with MVC prescription | ||||
---|---|---|---|---|
Univariate | Multivariate | |||
OR (CI 95%) | p | OR (CI 95%) | p | |
Period of test: | ||||
Before 2011 | 4.16 (2.51–6.89) | < 0.01 | 3.65 (2.17–6.13) | < 0.01 |
After 2011 | 1 | 1 | ||
Age (years): | 0.26 | |||
< 35 | 0.60 (0.25–1.45) | |||
35–43 | 0.68 (0.35–1.32) | |||
44–51 | 1.1 (0.63–1.93) | |||
> 51 | 1 | |||
Time between ART initiation and tropism (years): | 0.03 | |||
< 5 | 0.50 (0.27–0.92) | |||
5–10 | 0.88 (0.49–1.58) | |||
> 10 | 1 | |||
Number of previous ART regimens: | < 0.01 | |||
< 4 | 0.24 (0.11–0.51) | 0.34 (0.15–0.74) | < 0.01 | |
4–5 | 0.25 (0.11–0.55) | 0.32 (0.14–0.74) | < 0.01 | |
6–10 | 0.39 (0.19–0.79) | 0.46 (0.22–0.97) | 0.04 | |
> 10 | 1 | 1 | ||
CD4 count (/mm3): | 0.02 | |||
≤200 | 0.34 (0.13–0.85) | |||
201–500 | 0.86 (0.52–1.42) | |||
> 500 | 1 | |||
Reason for tropism performance: | ||||
Virological failure | 1.95 (1.20–3.16) | < 0.01 | 1.10 (0.62–1.98) | 0.73 |
Other | 1 | 1 |